Risinger J I, Berchuck A, Kohler M F, Boyd J
Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Triangle Park, North Carolina 27709.
Nat Genet. 1994 May;7(1):98-102. doi: 10.1038/ng0594-98.
Expression of the E-cadherin cell adhesion molecule is reduced in several types of human carcinomas, and the protein serves as an invasion suppressor in vitro. To determine if mutations of the E-cadherin gene (on chromosome 16q22) contribute to epithelial tumorigenesis, 135 carcinomas of the endometrium and ovary were examined for alterations in the E-cadherin coding region. Four mutations were identified: one somatic nonsense and one somatic missense mutation, both with retention of the wild-type alleles, and two missense mutations with somatic loss of heterozygosity in the tumour tissue. These data support the classification of E-cadherin as a human tumour suppressor gene.
E-钙黏蛋白细胞黏附分子在几种人类癌症中表达降低,并且该蛋白在体外作为一种侵袭抑制因子发挥作用。为了确定E-钙黏蛋白基因(位于16号染色体q22区域)的突变是否促进上皮肿瘤发生,研究人员检测了135例子宫内膜癌和卵巢癌中E-钙黏蛋白编码区的改变。共鉴定出4个突变:1个体细胞无义突变和1个体细胞错义突变,二者均保留野生型等位基因,以及2个错义突变,在肿瘤组织中存在体细胞杂合性缺失。这些数据支持将E-钙黏蛋白归类为人类肿瘤抑制基因。